Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.70 -0.76 (-5.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Common Equity (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) posted Common Equity of $171.81 million for Q2 2026, down 25.6% from $231.05 million a year earlier and down 10.2% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Common Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcturus Therapeutics Holdings' Common Equity came in at $213.99 million, down 11.2% from FY2024.

  • Annual Common Equity shows a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
  • In prior years, Arcturus Therapeutics Holdings' Common Equity was $240.98 million in FY2024 (-13.5%), $278.51 million in FY2023 (+3.0%), $270.31 million in FY2022 (+18.4%) and $228.21 million in FY2021 (-42.5%).
  • The Q2 2026 figure stands as the lowest quarterly Common Equity since Q3 2022.
  • On a year-over-year basis, Common Equity has declined in each of the last ten quarters, with an average decline of 13.9% over the last eight quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q3 2023, with growth of 92.3%; the weakest was Q1 2022, with a decline of 47.6%.
  • According to Business Quant data, Common Equity for the three prior quarters was $191.36 million (Q1 2026), $213.99 million (Q4 2025) and $224.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Arcturus Therapeutics Holdings 411.00 Mn -403.13 Mn - 171.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.81 Mn
Mar 31, 2026 191.36 Mn
Dec 31, 2025 213.99 Mn
Sep 30, 2025 224.56 Mn
Jun 30, 2025 231.05 Mn
Mar 31, 2025 233.76 Mn
Dec 31, 2024 240.98 Mn
Sep 30, 2024 261.87 Mn
Jun 30, 2024 258.58 Mn
Mar 31, 2024 263.97 Mn
Dec 31, 2023 278.51 Mn
Sep 30, 2023 280.06 Mn
Jun 30, 2023 285.18 Mn
Mar 31, 2023 329.25 Mn
Dec 31, 2022 270.31 Mn
Sep 30, 2022 145.67 Mn
Jun 30, 2022 170.72 Mn
Mar 31, 2022 184.75 Mn
Dec 31, 2021 228.21 Mn
Sep 30, 2021 259.13 Mn
API Access

Arcturus Therapeutics Holdings Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ARCT&period=max&api_key=YOUR_API_KEY